SG Americas Securities’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-202,239
| Closed | -$2.82M | – | 3469 |
|
|
2022
Q3 | $2.82M | Buy |
202,239
+89,125
| +79% | +$1.44M | 0.03% | 436 |
|
|
2022
Q2 | $1.56M | Buy |
+113,114
| New | +$1.81M | 0.02% | 911 |
|
|
2021
Q4 | – | Sell |
-37,988
| Closed | -$564K | – | 3926 |
|
|
2021
Q3 | $564K | Buy |
37,988
+17,423
| +85% | +$279K | ﹤0.01% | 2386 |
|
|
2021
Q2 | $411K | Sell |
20,565
-4,138
| -17% | -$82K | ﹤0.01% | 2030 |
|
|
2021
Q1 | $570K | Sell |
24,703
-6,922
| -22% | -$193K | ﹤0.01% | 1932 |
|
|
2020
Q4 | $781K | Buy |
31,625
+7,469
| +31% | +$248K | ﹤0.01% | 1681 |
|
|
2020
Q3 | $1M | Buy |
24,156
+16,236
| +205% | +$746K | 0.01% | 1172 |
|
|
2020
Q2 | $379K | Sell |
7,920
-27,427
| -78% | -$2.12M | ﹤0.01% | 2342 |
|
|
2020
Q1 | $2.23M | Buy |
35,347
+30,957
| +705% | +$2.78M | 0.02% | 747 |
|
|
2019
Q4 | $544K | Sell |
4,390
-2,155
| -33% | -$193K | 0.01% | 1702 |
|
|
2019
Q3 | $434K | Buy |
6,545
+3,338
| +104% | +$224K | ﹤0.01% | 1978 |
|
|
2019
Q2 | $255K | Sell |
3,207
-1,696
| -35% | -$152K | ﹤0.01% | 2269 |
|
|
2019
Q1 | $548K | Sell |
4,903
-15,426
| -76% | -$1.69M | 0.01% | 1771 |
|
|
2018
Q4 | $2.05M | Buy |
20,329
+1,700
| +9% | +$176K | 0.02% | 865 |
|
|
2018
Q3 | $2.35M | Buy |
18,629
+15,611
| +517% | +$1.65M | 0.02% | 1045 |
|
|
2018
Q2 | $253K | Sell |
3,018
-32,069
| -91% | -$2.35M | ﹤0.01% | 2451 |
|
|
2018
Q1 | $2.16M | Buy |
35,087
+6,556
| +23% | +$395K | 0.02% | 834 |
|
|
2017
Q4 | $1.67M | Buy |
28,531
+15,904
| +126% | +$1M | 0.02% | 1016 |
|
|
2017
Q3 | $733K | Buy |
12,627
+10,689
| +552% | +$1.15M | 0.01% | 1508 |
|
|
2017
Q2 | $235K | Buy |
+1,938
| New | +$224K | ﹤0.01% | 2309 |
|
|
2017
Q1 | – | Sell |
-1,940
| Closed | -$211K | – | 3621 |
|
|
2016
Q4 | $211K | Sell |
1,940
-1,909
| -50% | -$227K | ﹤0.01% | 2305 |
|
|
2016
Q3 | $634K | Sell |
3,849
-8,045
| -68% | -$1.27M | 0.01% | 1508 |
|
|
2016
Q2 | $1.7M | Buy |
11,894
+4,443
| +60% | +$648K | 0.01% | 946 |
|
|
2016
Q1 | $957K | Buy |
7,451
+5,173
| +227% | +$611K | 0.01% | 1341 |
|
|
2015
Q4 | $340K | Sell |
2,278
-18,212
| -89% | -$3.08M | ﹤0.01% | 1844 |
|
|
2015
Q3 | $3.4M | Buy |
20,490
+14,631
| +250% | +$3.22M | 0.02% | 471 |
|
|
2015
Q2 | $1.41M | Buy |
5,859
+1,788
| +44% | +$476K | 0.01% | 880 |
|
|
2015
Q1 | $1.15M | Sell |
4,071
-1,666
| -29% | -$361K | 0.01% | 1078 |
|
|
2014
Q4 | $895K | Buy |
5,737
+3,736
| +187% | +$690K | ﹤0.01% | 1281 |
|
|
2014
Q3 | $474K | Sell |
2,001
-167
| -8% | -$42.6K | ﹤0.01% | 1495 |
|
|
2014
Q2 | $513K | Buy |
2,168
+122
| +6% | +$32.2K | ﹤0.01% | 1669 |
|
|
2014
Q1 | $675K | Buy |
+2,046
| New | +$690K | ﹤0.01% | 1310 |
|
|
2013
Q4 | – | Sell |
-2,579
| Closed | -$178K | – | 3095 |
|
|
2013
Q3 | $178K | Buy |
+2,579
| New | +$127K | ﹤0.01% | 2263 |
|
Other funds holding ICPT
EAM
N
SG Americas Securities's ICPT Position: Q4 2022 in Review
SG Americas Securities sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2022, closing a stake of 202,239 shares — an estimated $2.82M sold.
SG Americas Securities first reported a position in ICPT in Q3 2013 and held it in 33 quarters. The position peaked at $3.4M in Q3 2015. 144 funds tracked by Wall St. Rank hold ICPT as of Q4 2022.
- SG Americas Securities reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
- SG Americas Securities sold 202,239 Intercept Pharmaceuticals, Inc. shares in Q4 2022, an estimated $2.82M.
- SG Americas Securities first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 33 quarters.
- SG Americas Securities's Intercept Pharmaceuticals, Inc. position peaked at $3.4M in Q3 2015.
- 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2022.
Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.